Peroxisome proliferator activated receptors and stroke Jean-Charles FruchartRĂ©gis BordetPatrick Duriez Invited Commentary Pages: 331 - 332
C-reactive protein and risk of cardiovascular disease: Evidence and clinical application Paul M. RidkerShari S. BassukPeter P. Toth OriginalPaper Pages: 341 - 349
Microalbuminuria and diabetic cardiovascular disease Richard J. MacIsaacMark E. Cooper OriginalPaper Pages: 350 - 357
Implications of the heart protection study for reducing coronary events in high-risk patients William Virgil BrownWarren DavisMatthey Harris OriginalPaper Pages: 358 - 363
Isoprenoid metabolism and the pleiotropic effects of statins Ulrich LaufsJames K. Liao OriginalPaper Pages: 372 - 378
Reverse cholesterol transport: High-density lipoprotein’s magnificent mile Peter P. Toth OriginalPaper Pages: 386 - 393
In-hospital initiation of statin therapy in patients with acute coronary events Gregg C. Fonarow OriginalPaper Pages: 394 - 402
Toxicity of antilipidemic agents: Facts and fictions Antonios M. XydakisPeter H. Jones OriginalPaper Pages: 403 - 410
Magnetic resonance imaging of coronary atherosclerosis Zahi A. FayadRobin P. ChoudhuryValentin Fuster OriginalPaper Pages: 411 - 417
Niacin: A powerful adjunct to other lipid-lowering drugs in reducing plaque progression and acute coronary events Michael H. Davidson OriginalPaper Pages: 418 - 422